Whether an optimal level of IFN-γ must be maintained by the preimplantation human embryo to increase pregnancy success rates, particularly in women with SLE or chronic inflammatory diseases, merits further investigation. The gene discussed is IFNG; the disease is systemic lupus erythematosus.